IMPURITIES AVAILABLE FOR 'Ledipasvir'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Ledipasvir. Ledipasvir is a direct-acting antiviral agent used in combination with sofosbuvir for the treatment of chronic hepatitis C virus (HCV) infection, particularly genotypes 1, 4, 5, and 6. It works by inhibiting the HCV NS5A protein, which is essential for viral RNA replication and virion assembly. Ledipasvir is administered orally as part of a fixed-dose combination tablet, offering a high cure rate (SVR) with once-daily dosing. The drug is well tolerated, with common side effects including fatigue, headache, and nausea. It provides a shorter and interferon-free regimen, revolutionizing HCV therapy. Ledipasvir has minimal renal clearance and is primarily eliminated via the bile. When combined with sofosbuvir (as Harvoni), it achieves over 95% efficacy in curing chronic hepatitis C infections. Buy high quality Ledipasvir from Omsynth Lifesciences.